Wells Fargo’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$313M Sell
702,052
-4,117
-0.6% -$1.83M 0.06% 243
2025
Q1
$342M Buy
706,169
+16,517
+2% +$8.01M 0.08% 223
2024
Q4
$278M Sell
689,652
-140,568
-17% -$56.6M 0.06% 248
2024
Q3
$386M Buy
830,220
+11,856
+1% +$5.51M 0.09% 198
2024
Q2
$384M Buy
818,364
+50,797
+7% +$23.8M 0.09% 193
2024
Q1
$321M Buy
767,567
+18,601
+2% +$7.78M 0.08% 217
2023
Q4
$305M Sell
748,966
-31,321
-4% -$12.7M 0.08% 213
2023
Q3
$271M Sell
780,287
-27,328
-3% -$9.5M 0.08% 215
2023
Q2
$284M Buy
807,615
+25,507
+3% +$8.98M 0.08% 221
2023
Q1
$246M Buy
782,108
+33,181
+4% +$10.5M 0.07% 232
2022
Q4
$216M Sell
748,927
-29,344
-4% -$8.47M 0.06% 252
2022
Q3
$225M Sell
778,271
-21,431
-3% -$6.21M 0.07% 236
2022
Q2
$225M Sell
799,702
-51,380
-6% -$14.5M 0.07% 237
2022
Q1
$222M Buy
851,082
+5,278
+0.6% +$1.38M 0.06% 270
2021
Q4
$186M Sell
845,804
-285,787
-25% -$62.8M 0.05% 303
2021
Q3
$205M Sell
1,131,591
-41,789
-4% -$7.58M 0.05% 392
2021
Q2
$237M Sell
1,173,380
-56,679
-5% -$11.4M 0.05% 351
2021
Q1
$264M Sell
1,230,059
-75,085
-6% -$16.1M 0.06% 310
2020
Q4
$308M Sell
1,305,144
-170,206
-12% -$40.2M 0.07% 256
2020
Q3
$401M Sell
1,475,350
-51,698
-3% -$14.1M 0.11% 177
2020
Q2
$443M Buy
1,527,048
+187,264
+14% +$54.4M 0.13% 159
2020
Q1
$319M Buy
1,339,784
+14,132
+1% +$3.36M 0.11% 187
2019
Q4
$290M Sell
1,325,652
-44,735
-3% -$9.79M 0.08% 249
2019
Q3
$232M Sell
1,370,387
-111,609
-8% -$18.9M 0.07% 296
2019
Q2
$272M Sell
1,481,996
-95,420
-6% -$17.5M 0.08% 245
2019
Q1
$290M Sell
1,577,416
-332,587
-17% -$61.2M 0.09% 221
2018
Q4
$317M Sell
1,910,003
-241,710
-11% -$40.1M 0.11% 192
2018
Q3
$415M Buy
2,151,713
+64,205
+3% +$12.4M 0.12% 173
2018
Q2
$355M Buy
2,087,508
+82,811
+4% +$14.1M 0.11% 195
2018
Q1
$327M Sell
2,004,697
-122,395
-6% -$19.9M 0.1% 208
2017
Q4
$319M Buy
2,127,092
+149,823
+8% +$22.5M 0.09% 218
2017
Q3
$301M Buy
1,977,269
+61,042
+3% +$9.28M 0.09% 218
2017
Q2
$247M Buy
1,916,227
+83,314
+5% +$10.7M 0.08% 263
2017
Q1
$200M Buy
1,832,913
+301,675
+20% +$33M 0.07% 307
2016
Q4
$113M Sell
1,531,238
-109,958
-7% -$8.1M 0.04% 468
2016
Q3
$143M Sell
1,641,196
-186,554
-10% -$16.3M 0.05% 390
2016
Q2
$157M Sell
1,827,750
-151,467
-8% -$13M 0.06% 339
2016
Q1
$157M Sell
1,979,217
-631,608
-24% -$50.2M 0.06% 338
2015
Q4
$329M Buy
2,610,825
+1,440,201
+123% +$181M 0.13% 178
2015
Q3
$122M Sell
1,170,624
-103,881
-8% -$10.8M 0.05% 392
2015
Q2
$157M Sell
1,274,505
-22,669
-2% -$2.8M 0.06% 350
2015
Q1
$153M Sell
1,297,174
-367,769
-22% -$43.4M 0.06% 352
2014
Q4
$198M Buy
1,664,943
+374,809
+29% +$44.5M 0.08% 296
2014
Q3
$145M Buy
1,290,134
+616,976
+92% +$69.3M 0.06% 354
2014
Q2
$63.7M Sell
673,158
-1,058,191
-61% -$100M 0.03% 659
2014
Q1
$122M Sell
1,731,349
-454,574
-21% -$32.1M 0.05% 409
2013
Q4
$162M Buy
2,185,923
+179,426
+9% +$13.3M 0.07% 316
2013
Q3
$152M Buy
2,006,497
+103,266
+5% +$7.83M 0.07% 314
2013
Q2
$152M Buy
+1,903,231
New +$152M 0.08% 298